A part of the work shown in this article was founded by the Center of Integrative Mammalian Research of Ross University School of Veterinary Medicine (RUSVM), Saint Kitts and Nevis. The financial aid provided by the Department of Veterinary Biomedical Sciences of Long Island University College of Veterinary Medicine is greatly appreciated.

The following protocol describes a survival surgery. Therefore, the highest aseptic and surgical practice is applied. All animal experiments were performed in compliance with institutional guidelines and approved by the Institutional Animal Care and Use Committee. To eliminate gender&#160;and strain-based differences in IRI effects, only male C57BL6 mice were used in the study. All animals were matched in age and weight to produce comparable results.
1. Preparation
NOTE: A timeline of the different experimental phases and interventions is shown in Figure 1A.
<ol>
	<li>Clean and disinfect the surgical table before each procedure. Prepare and place all required materials (sterilized instruments and cotton swabs, sterile gauze and drapes, pre-diluted anesthetics, heating pad, sterilized vascular clamp, sterile saline solution, and skin antiseptics and suture) on the surgical table (see the Table of Materials).</li>
	<li>Anesthetize male C57BL6 mice (age range 11-13 weeks) by intraperitoneal injection of ketamine/xylazine (100 mg/kg and 20 mg/kg of body weight, respectively, previously diluted in sterile saline). 
	NOTE: Skilled animal handling is essential to minimize stress for the animal, as stress responses can negatively affect the action of anesthetics.</li>
	<li>After ketamine/xylazine administration, shave the surgical area on the right flank using a razor blade and soap. 
	NOTE: Shaving the skin improves wound healing as well as the general outcomes of survival surgeries.</li>
	<li>Disinfect the skin in the surgical area with 70% alcohol first and then with povidone iodine solution using a cotton swab.</li>
	<li>After the skin preparation, place the mouse on a heating table in a ventral decubitus position and stabilize the body temperature at 37 &#176;C (monitored through rectal and pad sensor probes). 
	NOTE: Kidneys are more easily accessed and surgically exposed when placed in ventral decubitus rather than lateral.</li>
	<li>While the body temperature is stabilized, apply eye ointment to the eyes of the mouse. 
	NOTE: Dissociative anesthetics, such as ketamine, cause the animal&#39;s eyes to remain open while anesthetized.</li>
</ol>
2. Surgery
<ol>
	<li>Once the pain reflexes are absent (toe pinching with tweezers), perform an approximately 1 cm dorso-lateral surgical incision on the right flank using a scalpel blade. Start the incision behind the last rib and continue caudally approximately 1 cm parallel to the lumbar midline.</li>
	<li>Transect the abdominal musculature using scissors to visualize the retroperitoneal space. Remove the small amounts of blood produced during the sectioning of the muscles using sterile cotton swabs. 
	NOTE: Because the dorso-lateral approach is used, the retroperitoneum, and not the peritoneal cavity, is accessed with this procedure.</li>
	<li>Push the right kidney out from the abdominal cavity. Use Graefe forceps to expose the kidney carefully. 
	NOTE: Always keep forceps closed to avoid traumatic injury to the kidney when placed on the abdomen and use it only to carefully push and guide the kidney towards the surgical incision and out of it.</li>
	<li>Slowly expose the right kidney and identify the renal pedicle. Carefully remove the adipose tissue around the pedicle.</li>
	<li>To induce ischemia, place the vascular clamp over the renal artery and vein present in the renal pedicle, avoiding clamping the adjacent ureter. Use a Halsted-Mosquito hemostat for manipulating the vascular clamp. 
	NOTE: Ischemia is confirmed by the visualization of a change in color of the kidney from red-pink to dark purple (Figure 1B).</li>
	<li>Cover the clamped kidney with sterile gauze soaked in saline to avoid desiccation and leave it for 30 min.</li>
	<li>Monitor anesthesia depth and humidity of the gauze periodically during this time. 
	NOTE: The induction dose of anesthesia is sufficient to provide analgesia until the end of the ischemic event; hence, no additional anesthetic injections are required.</li>
	<li>Shortly before the end of the ischemia period, remove the gauze and uncover the kidney. Hold the Halsted-Mosquito hemostat, ready for clamp removal.</li>
	<li>At minute 30, open the vascular clamp with the hemostat and remove it from the renal pedicle to allow reperfusion of the kidney. 
	NOTE: Reperfusion is confirmed by the visualization of a change in the color of the kidney from dark purple to red-pink (Figure 1C).</li>
	<li>Perform the same procedures described above for sham animals without clamping of the renal pedicle.</li>
	<li>After verification of the kidney color change, return the kidney to the abdominal cavity. Close the abdominal muscles with absorbable suture 5-0 using a cruciate pattern. 
	NOTE: A second injection of anesthetics may be required to maintain analgesia during the suturing of the muscles and the skin. Half of the initial dose has proved effective in providing analgesia until the conclusion of the surgery.</li>
	<li>Close the skin with absorbable suture 5-0 using a horizontal mattress pattern. Clean the wound with a povidone iodine solution using a cotton swab.</li>
</ol>
3. Recovery and post-surgery
NOTE: As post-surgical time is the actual reperfusion time, proper post-surgical care is ethically mandatory and scientifically relevant. Reperfusion times can be selected as required by the researcher. Reperfusion times of 4 h, 8 h, 16 h, 1 day, 2 days, 4 days, and 7 days are compared to obtain a sequential overview of pathological changes induced by renal IRI.
<ol>
	<li>Keep the mouse on the heating pad until it starts recovering from anesthesia. 
	NOTE: It is recommended to wait until the mouse begins moving its legs and attempts to move around. In cases when additional anesthetic injections are required during the surgery, the recovery time is longer. Atipamezole, an alpha-2 receptor antagonist, can be administered at a dose of 0.5 mg/kg of body weight intraperitoneally to reverse the xylazine effects and shorten the recovery phase. For pain management, buprenorphine (0.1 mg/kg of body weight, intraperitoneally) is administered pre-operatively and every 6 hours during the recovery and post-surgical phase. The use of non-steroidal anti-inflammatory drugs is discouraged as several drugs in this family induce nephrotoxicity and can, therefore, alter the results.</li>
	<li>After recovery from anesthesia, place the mouse back in its cage with free access to water and food. 
	NOTE: Mashed food can be provided in a Petri dish as well as material for hiding and playing (e.g., paper sheets, paper towel tubes).</li>
	<li>Monitor the mouse daily to assess wound healing, food and water intake, body weight, and behavior. 
	NOTE: Wound healing status was assessed using the following scale: 1, dry; 2, wet; 3, partially opened; 4, opened. Fast wound healing was documented in this study, with more than 90% of dry wounds after day 2.</li>
</ol>
4. Euthanasia and sample collection
<ol>
	<li>Euthanize the mice with sodium pentobarbital administered intraperitoneally at a dose that is twice the anesthetic dose for mice (100 mg/kg).</li>
	<li>Collect fluid and tissue samples as required. 
	NOTE: Both kidneys, whole blood (for blood cell count), serum (for blood biochemistry), urine, the heart, and the lungs were collected. A few microliters of serum are needed for blood biochemistry analysis (blood urea nitrogen (BUN), creatinine, electrolytes). If required, 24 h before euthanasia, mice can be placed into metabolic cages to collect a higher urine volume that allows the determination of renal function parameters.</li>
</ol>

<ol>
	<li>Ray, S. C., Mason, J., O'Connor, P. M. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Ischemic+renal+injury:+can+renal+anatomy+and+associated+vascular+congestion+explain+why+the+medulla+and+not+the+cortex+is+where+the+trouble+starts.">Ischemic renal injury: can renal anatomy and associated vascular congestion explain why the medulla and not the cortex is where the trouble starts.</a> Seminars in Nephrology. 39 (6), 520-529 (2019).</li><li>Weight, S. C., Bell, P. R., Nicholson, M. L. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Renal+ischaemia--reperfusion+injury.">Renal ischaemia--reperfusion injury.</a> The British Journal of Surgery. 83 (2), 162-170 (1996).</li><li>Ratliff, B. B., Abdulmahdi, W., Pawar, R., Wolin, M. S. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Oxidant+mechanisms+in+renal+injury+and+disease.">Oxidant mechanisms in renal injury and disease.</a> Antioxidants &amp; Redox Signaling. 25 (3), 119-146 (2016).</li><li>Schrier, R. W., Wang, W., Poole, B., Mitra, A. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Acute+renal+failure:+definitions,+diagnosis,+pathogenesis,+and+therapy.">Acute renal failure: definitions, diagnosis, pathogenesis, and therapy.</a> The Journal of Clinical Investigation. 114 (1), 5-14 (2004).</li><li>Fern&#225;ndez, A. R., S&#225;nchez-Tarjuelo, R., Cravedi, P., Ochando, J., L&#243;pez-Hoyos, M. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Review:+Ischemia+reperfusion+injury-a+translational+perspective+in+organ+transplantation.">Review: Ischemia reperfusion injury-a translational perspective in organ transplantation.</a> International Journal of Molecular Sciences. 21 (22), 8549 (2020).</li><li>Wu, C. -. L., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Tubular+peroxiredoxin+3+as+a+predictor+of+renal+recovery+from+acute+tubular+necrosis+in+patients+with+chronic+kidney+disease.">Tubular peroxiredoxin 3 as a predictor of renal recovery from acute tubular necrosis in patients with chronic kidney disease.</a> Scientific Reports. 7 (1), 43589 (2017).</li><li>Nishida, K., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Systemic+and+sustained+thioredoxin+analogue+prevents+acute+kidney+injury+and+its-associated+distant+organ+damage+in+renal+ischemia+reperfusion+injury+mice.">Systemic and sustained thioredoxin analogue prevents acute kidney injury and its-associated distant organ damage in renal ischemia reperfusion injury mice.</a> Scientific Reports. 10 (1), 20635 (2020).</li><li>Mishra, J., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Neutrophil+gelatinase-associated+lipocalin+(NGAL)+as+a+biomarker+for+acute+renal+injury+after+cardiac+surgery.">Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery.</a> Lancet. 365 (9466), 1231-1238 (2005).</li><li>Han, W. K., Bailly, V., Abichandani, R., Thadhani, R., Bonventre, J. V. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Kidney+injury+molecule-1+(KIM-1):+A+novel+biomarker+for+human+renal+proximal+tubule+injury.">Kidney injury molecule-1 (KIM-1): A novel biomarker for human renal proximal tubule injury.</a> Kidney International. 62 (1), 237-244 (2002).</li><li>Coca, S. G. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Kidney+injury+biomarkers+with+clinical+utility:+has+Godot+finally+arrived.">Kidney injury biomarkers with clinical utility: has Godot finally arrived.</a> American Journal of Nephrology. 50 (5), 357-360 (2019).</li><li>Godoy, J. R., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Segment-specific+overexpression+of+redoxins+after+renal+ischemia+and+reperfusion:+protective+roles+of+glutaredoxin+2,+peroxiredoxin+3,+and+peroxiredoxin+6.">Segment-specific overexpression of redoxins after renal ischemia and reperfusion: protective roles of glutaredoxin 2, peroxiredoxin 3, and peroxiredoxin 6.</a> Free Radical Biology &amp; Medicine. 51 (2), 552-561 (2011).</li><li>Wei, Q., Dong, Z. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Mouse+model+of+ischemic+acute+kidney+injury:+technical+notes+and+tricks.">Mouse model of ischemic acute kidney injury: technical notes and tricks.</a> American Journal of Physiology - Renal Physiology. 303 (11), 1487-1494 (2012).</li><li>Gaut, J. P., Liapis, H. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Acute+kidney+injury+pathology+and+pathophysiology:+a+retrospective+review.">Acute kidney injury pathology and pathophysiology: a retrospective review.</a> Clinical Kidney Journal. 14 (2), 526-536 (2021).</li><li>Le Clef, N., Verhulst, A., D'Haese, P. C., Vervaet, B. A. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Unilateral+renal+ischemia-reperfusion+as+a+robust+model+for+acute+to+chronic+kidney+injury+in+mice.">Unilateral renal ischemia-reperfusion as a robust model for acute to chronic kidney injury in mice.</a> PLoS One. 11 (3), 0152153 (2016).</li><li>Pelkey, T. J., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Minimal+physiologic+temperature+variations+during+renal+ischemia+alter+functional+and+morphologic+outcome.">Minimal physiologic temperature variations during renal ischemia alter functional and morphologic outcome.</a> Journal of Vascular Surgery. 15 (4), 619-625 (1992).</li><li>Kennedy, S. E., Erlich, J. H. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Murine+renal+ischaemia-reperfusion+injury.">Murine renal ischaemia-reperfusion injury.</a> Nephrology. 13 (5), 390-396 (2008).</li><li>Skrypnyk, N. I., Harris, R. C., de Caestecker, M. P. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Ischemia-reperfusion+model+of+acute+kidney+injury+and+post+injury+fibrosis+in+mice.">Ischemia-reperfusion model of acute kidney injury and post injury fibrosis in mice.</a> Journal of Visualized Experiments: JoVE. (78), e50495 (2013).</li><li>Hesketh, E. E., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Renal+ischaemia+reperfusion+injury:+a+mouse+model+of+injury+and+regeneration.">Renal ischaemia reperfusion injury: a mouse model of injury and regeneration.</a> Journal of Visualized Experiments: JoVE. (88), e51816 (2014).</li><li>Wei, J., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=New+mouse+model+of+chronic+kidney+disease+transitioned+from+ischemic+acute+kidney+injury.">New mouse model of chronic kidney disease transitioned from ischemic acute kidney injury.</a> American Journal of Physiology. Renal Physiology. 317 (2), 286-295 (2019).</li><li>Basile, D. P., Leonard, E. C., Tonade, D., Friedrich, J. L., Goenka, S. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Distinct+effects+on+long-term+function+of+injured+and+contralateral+kidneys+following+unilateral+renal+ischemia-reperfusion.">Distinct effects on long-term function of injured and contralateral kidneys following unilateral renal ischemia-reperfusion.</a> American Journal of Physiology - Renal Physiology. 302 (5), 625-635 (2012).</li><li>Polichnowski, A. J., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Pathophysiology+of+unilateral+ischemia-reperfusion+injury:+importance+of+renal+counterbalance+and+implications+for+the+AKI-CKD+transition.">Pathophysiology of unilateral ischemia-reperfusion injury: importance of renal counterbalance and implications for the AKI-CKD transition.</a> American Journal of Physiology. Renal Physiology. 318 (5), 1086-1099 (2020).</li></ol>

The authors declare that there are no conflicts of interest regarding this article.

Mouse renal IRI models are popular in biomedical research due to their relatively low operational costs and the availability of diverse transgenic models12. The unilateral renal IRI model presented here mimics characteristic pathological changes observed in human renal IRI such as tubular dilatation, necrosis, and fibrosis13. These results are based on varying reperfusion times.
Critical steps of this protocol include the maintenance of constant body temperature and correct placement of the vascular clamp in the renal pedicle. Body temperature influences the animal&#39;s metabolism14, altering the experimental results both at the physiological and cellular levels15. In this model, the body temperature was stabilized before surgery using rectal and pad sensor probes. In addition, continuous monitoring of the body temperature during the whole surgical procedure is highly recommended, especially before placing the vascular clamp to induce ischemia.
The exposure of the kidney and the proper placement of the vascular clamp are also critical for the success of the experiment. Damage to the renal capsule by improper handling of the forceps during exposure of the kidney through the surgical incision will result in perirenal hemorrhage and inflammation. The vascular clamp should be placed on the renal pedicle occluding the renal artery and the renal vein without affecting the ureter and the suprarenal arteries. Critical for this step is the careful dissection of the adipose tissue surrounding the renal hilum14,16.
This model is cost- and time-effective. Anesthetic consumption per mouse was 156.47 &#177; 37.88 &#181;L (mean &#177; SD, n = 17) of a prediluted ketamine/xylazine cocktail (1:10 ketamine, 1:50 xylazine, in saline; stock solution concentration, 100 mg/mL both). Surgery can be performed in a relatively short period. The total surgery time per mouse was 53 &#177; 5.23 min (mean &#177; SD, n = 17). With trained personnel, several surgeries can be performed at the same time. In our group, one experienced researcher performed the surgery until the clamp was released from the renal pedicle, while a second one took over from wound closing until the recovery of the mouse. With this approach, we were able to perform a high number of surgeries on a single day. In this model, we used the dorsolateral approach, which results in less trauma and reduced fluid and heat loss from the abdominal cavity as compared with the midline approach16.
Previously published protocols have described the renal pedicle clamping technique to induce acute kidney injury in mice17,18,19. However, in those studies, a contralateral nephrectomy was performed in addition to the unilateral IRI with ischemic times ranging from 15 to 26 min. In this protocol, we induced unilateral ischemia for 30 min while preserving the contralateral kidney. This resulted in a survival rate of 100%. However, this model is not suitable to induce azotemic renal damage due partly to the compensatory effect exerted by the non-surgically intervened contralateral kidney. However, keeping one kidney unaffected in the same animal offers the advantage of using longer ischemia times with a higher survival rate. In addition to this, the contralateral kidney can be utilized to assess possible side effects of test drugs or treatments applied during the experimental procedure and to study kidney-kidney crosstalk effects20,21. For example, this model has been useful in showing reactive oxygen species-induced alterations at the cellular level both in the IRI and contralateral, non-surgically intervened kidney11.
This model has a potential application in studies aiming to identify and characterize markers of unilateral renal damage, renal crosstalk effects, post-renal IRI-induced hemodynamic changes, and potential nephrotoxic effects of drug candidates to be used in renal IRI. This detailed description of the main pathological changes serves as a valuable tool to select the most suitable time to study specific cellular processes, from inflammation and necrosis (4 h to 2 days) to regeneration (4 days) and fibrosis (7 days and later).

The kidneys are among the highest perfused organs in the body and are extremely susceptible to changes in blood perfusion1. Renal ischemia-reperfusion injury (IRI) remains the leading cause of acute renal failure2,3 and is associated with high morbidity and high mortality in hospitalized patients4. With limited therapeutic options available,4,5 renal IRI is currently the focus of several research efforts in biomedicine6,7 aiming for the development of novel therapeutic targets and the characterization of early and sensitive markers of renal injury8,9,10. Identifying a reliable, time&#160;and cost-effective animal model is considered essential to meet these needs. This paper presents a simple and effective mouse model of unilateral renal IRI. Ischemia is induced by clamping of the right renal pedicle for 30 min11,12. A crucial part of this model is choosing the most suitable reperfusion time that will reproduce the pathological events of interest, such as tubular necrosis, polymorphonuclear inflammatory cell infiltration, or fibrosis. Therefore, researchers are provided with this sequential overview of representative pathological changes expected in the IRI kidney.

<table><tbody><tr><td>Atipamezole hydrochloride</td><td>Penn Veterinary Supply, Inc., PA, USA</td><td>PVS8700</td><td>5 mg/mL</td></tr><tr><td>Buprenorphine</td><td>Penn Veterinary Supply, Inc., PA, USA</td><td>PRMBURPEN22</td><td>0.3 mg/mL</td></tr><tr><td>Commercial euthanasia solution</td><td>various suppliers</td><td>na</td><td>e.g., Euthasol Virbac (sodium pentobarbital 390 mg/mL + sodium phenytoin 50 mg/mL)</td></tr><tr><td>Eye ointment Puralube</td><td>Dechra Veterinary Products, KS, USA</td><td>na</td><td>3.5 g (1/8 oz)</td></tr><tr><td>Heating pad RightTempJr</td><td>Kent Scientific, CT, USA</td><td>&amp;nbsp;RT-JR-20</td><td>Consider the one with two temperature probes</td></tr><tr><td>Ketamine hydrochloride</td><td>Penn Veterinary Supply, Inc., PA, USA</td><td>VED1220</td><td>100 mg/ml</td></tr><tr><td>S&amp;amp;T Vascular clamp</td><td>Fine Science Tools, Inc., Germany</td><td>00398-02</td><td>Jaw dimensions: 5.5 x 1.5 mm; length: 11 mm</td></tr><tr><td>Sterile Disposable Towel Drapes </td><td>Kent Scientific, CT, USA </td><td>SURGI-5023-3 </td><td>Disposable, individualy packed </td></tr><tr><td>Surgical instruments (Graefe forceps, Halsted-Mosquito hemostat, scissors, etc)</td><td>Fine Science Tools, Inc., Germany</td><td>Various</td><td>Consider the extra fine straight scissor and the angled Graefe forceps</td></tr><tr><td>Vicryl suture</td><td>Ethicon US, LLC</td><td>J493G</td><td>Size 5-0</td></tr><tr><td>Xylazine hydrochloride</td><td>Penn Veterinary Supply, Inc., PA, USA</td><td>VAM4821</td><td>100 mg/mL</td></tr></tbody></table>

an effective mouse model of unilateral renal ischemia-reperfusion injury

Ischemia-reperfusion injury (IRI) is the leading cause of acute renal failure and is a significant contributor to delayed graft function. Animal models are the only available resources that mimic the complexities of the IRI-associated damage encountered in vivo. This paper describes an effective mouse model of unilateral renal IRI that delivers highly reproducible data. Ischemia is induced by occluding the right renal pedicle for 30 min followed by reperfusion. In addition to the surgical procedure, a sequential overview of the expected physiological and histopathological changes following renal IRI will be provided by comparing data from seven different reperfusion times (4 h, 8 h, 16 h, 1 day, 2 days, 4 days, and 7 days). Critical data for planning experiments ahead, such as mean surgical time, average anesthetic consumption, and body weight changes over time, will be shared. This work will help researchers implement a reliable renal IRI model and select the appropriate reperfusion time that aligns with their intended investigative goals.

Physiological parameters 
Mice recovered from this unilateral renal IRI surgery uneventfully; appeared active and alert; and showed normal eating, drinking, and behavior by the following day. Some mice may have post-IRI body weight loss, although it is usually less than 10% of the initial body weight (Figure 2). Greater body weight losses (&#707;10%) can be detrimental, and those animals should be removed from the study. Sham-operated mice did not show body weight changes post-surgery (measured 24 h after surgery). Most mice recovered their initial body weight between days 4 and 7 post-surgery (see IRI 7-day group, Figure 2). Renal function can be assessed using traditional markers such as blood urea nitrogen (BUN) and creatinine. Additionally, electrolyte levels in serum (sodium, potassium, and chloride) and an automated differential blood count were included in the analysis.
Histopathological changes 
Assessment of histopathological findings was done using 4% paraformaldehyde-fixed, paraffin-embedded whole mid-sagittal sections of the kidney stained with hematoxylin/eosin (HE), periodic acid Schiff, and Masson&#39;s trichrome stains. The most evident changes produced by this unilateral renal IRI model can be seen at the cortico-medullary junction, specifically in the proximal tubules, thick ascending limbs of Henle&#39;s loop, and distal convoluted tubules, as well as in the tubular interstitium (see the legend for Figure 3). Microscopic images showing the most characteristic lesions following IRI in the kidney can be seen in Figure 3. A list of the sequential histopathological findings is provided in Table 1.
A tubular injury scoring system was developed to categorize the damage over time (Figure 4). In this, five defined alterations were assessed by three different evaluators: 1) tubular epithelial attenuation; 2) brush border loss; 3) tubular necrosis; 4) luminal obstruction; and 5) presence of proteinaceous cast. An assignment of &#34;1&#34; indicates that the alteration is present, &#34;0&#34; that it is absent.
<img alt="Figure 1" class="xfigimg" src="/files/ftp_upload/62749/62749fig01.jpg" /> 
Figure 1: Experimental renal IRI model in mouse. (A) Phases of experiments and interventions (anesthesia induction, ischemia, and reperfusion) are shown. Please note the changes in the color of the right kidney to dark red during ischemia (B) to pink during reperfusion (C). (D) Macroscopic appearance of the IRI right kidney (red arrow) compared to the contralateral non-IRI kidney of the same animal 24 h after surgery. Red arrow in (B) shows the position of the hemostatic clamp. Abbreviation: IRI = Ischemia-reperfusion injury. <a href="https://www.jove.com/files/ftp_upload/62749/62749fig01large.jpg" target="_blank">Please click here to view a larger version of this figure.</a>
<img alt="Figure 2" class="xfigimg" src="/files/ftp_upload/62749/62749fig02.jpg" /> 
Figure 2:&#160;Body weight of mice before and after renal IRI. Individual data are shown. Abbreviations: IRI = Ischemia-reperfusion injury; h = hours; d = days. <a href="https://www.jove.com/files/ftp_upload/62749/62749fig02large.jpg" target="_blank">Please click here to view a larger version of this figure.</a>
<img alt="Figure 3" class="xfigimg" src="/files/ftp_upload/62749/62749fig03.jpg" /> 
Figure 3: Typical microscopic lesions observed in the cortex and the cortico-medullary junction of IR-operated mice. Sham and different reperfusion times are shown (indicated above each picture). (A) Intact structures are shown in sham (magnification 40x; scale bar = 20 &#181;m). Arrows in IRI 4 h indicate the presence of proteinaceous cast in the tubular lumen (magnification 40x; scale bar = 20 &#181;m). Arrows in IRI 8 h show tubular dilatation (magnification 40x; scale bar = 50 &#181;m). Black arrow in IRI 16 h shows tubular cast in medullary segments; white arrows show areas of cellular necrosis (magnification 40x; scale bar = 50 &#181;m). Black arrows in IRI 1 d indicate tubular dilatation (magnification 10x; scale bar = 100 &#181;m). Black arrow in IRI 2 d shows enlarged cell nuclei; white arrowheads show areas of lymphocyte and macrophage infiltration (magnification 40x; scale bar = 50 &#181;m). White arrowheads in IRI 4 d indicate mitotic tubular cells (magnification 40x; scale bar = 50 &#181;m). Black arrow in IRI 7 d shows an area of focal fibrosis; white arrowhead shows an area of regeneration (magnification 20x; scale bar = 100 &#181;m). (B) PAS staining showing the renal cortex of mice during early reperfusion (4 h, 8 h, and 16 h). Note the progressive attenuation of the brush border (arrows). Magnifications 40x; scale bars = 50 &#181;m (C) Masson trichrome staining of sham and IRI 7 d mice showing areas of interstitial fibrosis (white arrows). Magnification 40x; scale bars = 50 &#181;m. Abbreviations: IRI = Ischemia-reperfusion injury; Glo = glomerulus; PCT = proximal convoluted tubule; DCT = distal convoluted tubule; CD = collecting duct; PAS = periodic acid Schiff; d = day. <a href="https://www.jove.com/files/ftp_upload/62749/62749fig03large.jpg" target="_blank">Please click here to view a larger version of this figure.</a>
<img alt="Figure 4" class="xfigimg" src="/files/ftp_upload/62749/62749fig04.jpg" /> 
Figure 4: Tubular injury score of sham- and IRI-operated mice. Scoring system scale 1 to 5 for tubular epithelial attenuation; brush border loss; tubular necrosis; luminal obstruction; and presence of proteinaceous cast. An assignment of &#34;1&#34; indicates that the alteration is present, &#34;0&#34; that it is absent. Individual values are shown. Bars represent mean &#177; SD (n = 4). Abbreviation: IRI = Ischemia-reperfusion injury. <a href="https://www.jove.com/files/ftp_upload/62749/62749fig04large.jpg" target="_blank">Please click here to view a larger version of this figure.</a>
<table border="1" fo:keep-together.within-page="1" fo:keep-with-next.within-page="always">
	<tbody>
		<tr>
			<td>Time after IRI</td>
			<td>Most significant pathological changes</td>
		</tr>
		<tr>
			<td>4 h</td>
			<td>Tubular obstruction</td>
		</tr>
		<tr>
			<td></td>
			<td>Protein cast in lumen</td>
		</tr>
		<tr>
			<td>8 h</td>
			<td>Tubular dilatation</td>
		</tr>
		<tr>
			<td></td>
			<td>Incipient necrosis</td>
		</tr>
		<tr>
			<td></td>
			<td>Attenuation of epithelium</td>
		</tr>
		<tr>
			<td>16 h</td>
			<td>Cellular necrosis</td>
		</tr>
		<tr>
			<td></td>
			<td>Tubular cast</td>
		</tr>
		<tr>
			<td></td>
			<td>Neutrophil infiltration</td>
		</tr>
		<tr>
			<td>1 day</td>
			<td>Necrosis</td>
		</tr>
		<tr>
			<td></td>
			<td>Tubular dilatation</td>
		</tr>
		<tr>
			<td></td>
			<td>Neutrophil infiltration</td>
		</tr>
		<tr>
			<td>2 days</td>
			<td>Tubular dilatation</td>
		</tr>
		<tr>
			<td></td>
			<td>Lymphocyte and macrophage infiltration</td>
		</tr>
		<tr>
			<td></td>
			<td>Enlarged cell nuclei</td>
		</tr>
		<tr>
			<td>4 days</td>
			<td>Prominent mitotic activity in tubule cells</td>
		</tr>
		<tr>
			<td>7 days</td>
			<td>Focal fibrosis</td>
		</tr>
		<tr>
			<td></td>
			<td>Areas of regeneration</td>
		</tr>
	</tbody>
</table>
Table 1: Most significant pathological changes over time. Diagnosed based on microscopic examination of 4-6 animals per group.

Watch this Scientific Journal Video about An Effective Mouse Model of Unilateral Renal Ischemia-Reperfusion Injury at JoVE.com

An Effective Mouse Model of Unilateral Renal Ischemia-Reperfusion Injury

Renal ischemia-reperfusion injury is associated with high morbidity and mortality in hospitalized patients. Here, we present a simple and effective mouse model of unilateral renal ischemia-reperfusion injury and provide a sequential overview of representative pathological changes observed in the kidney.

Ischemia-reperfusion injury (IRI) is the leading cause of acute renal failure and is a significant contributor to delayed graft function. Animal models ...

an-effective-mouse-model-unilateral-renal-ischemia-reperfusion

Research

JoVE Journal

Medicine

6.3K Views.  Long Island University College of Veterinary Medicine. Renal ischemia-reperfusion injury is associated with high morbidity and mortality in hospitalized patients. Here, we present a simple and effective mouse model of unilateral renal ischemia-reperfusion injury and provide a sequential overview of representative pathological changes observed in the kidney.

Video: An Effective Mouse Model of Unilateral Renal Ischemia-Reperfusion Injury

Use of a Hanging-weight System for Isolated Renal Artery Occlusion

In hospitalized patients, over 50% of cases of acute kidney injury (AKI) are caused by renal ischemia 1-3. A recent study of hospitalized patients revealed that only a mild increase in serum creatinine levels (0.3 to 0.4 mg/dl) is associated with a 70% greater risk of death than in persons without any increase 1. Along these lines, surgical procedures requiring cross-clamping of the aorta and renal vessels are associated with a renal failure rates of up to 30% 4. Similarly, AKI after cardiac surgery occurs in over 10% of patients under normal circumstances and is associated with dramatic increases in mortality. AKI are also common complications after liver transplantation. At least 8-17% of patients end up requiring renal replacement therapy 5. Moreover, delayed graft function due to tubule cell injury during kidney transplantation is frequently related to ischemia-associated AKI 6. Moreover, AKI occurs in approximately 20% of patients suffering from sepsis 6.The occurrence of AKI is associated with dramatic increases of morbidity and mortality 1. Therapeutic approaches are very limited and the majority of interventional trials in AKI have failed in humans. Therefore, additional therapeutic modalities to prevent renal injury from ischemia are urgently needed 3, 7-9. 
To elucidate mechanisms of renal injury due to ischemia and possible therapeutic strategies murine models are intensively required 7-13. Mouse models provide the possibility of utilizing different genetic models including gene-targeted mice and tissue specific gene-targeted mice (cre-flox system). However, murine renal ischemia is technically challenging and experimental details significantly influence results. We performed a systematic evaluation of a novel model for isolated renal artery occlusion in mice, which specifically avoids the use of clamping or suturing the renal pedicle 14. This model requires a nephrectomy of the right kidney since ischemia can be only performed in one kidney due to the experimental setting. In fact, by using a hanging-weight system, the renal artery is only instrumented once throughout the surgical procedure. In addition, no venous or urethral obstruction occurs with this technique. We could demonstrate time-dose-dependent and highly reproducible renal injury with ischemia by measuring serum creatinine. Moreover, when comparing this new model with conventional clamping of the whole pedicle, renal protection by ischemic preconditioning is more profound and more reliable. Therefore his new technique might be useful for other researchers who are working in the field of acute kidney injury.

A precise murine model for acute kidney injury (AKI) due to ischemia is an important tool to investigate acute kidney injury and possibly find therapeutic tools to treat renal injury. The hanging weight system offers a tool for immediate and reliable renal artery occlusion and reperfusion without causing renal congestion.

In hospitalized patients, over 50% of cases of acute kidney injury (AKI) are caused by renal ischemia 1-3. A recent study of hospitalized patients ...

Normothermic Cardiac Arrest and Cardiopulmonary Resuscitation: A Mouse Model of Ischemia-Reperfusion Injury

Acute Kidney Injury (AKI) is a common, highly lethal, complication of critical illness which has a high mortality1-4 and which is most 
frequently caused by whole-body hypoperfusion.5,6 Successful reproduction of whole-body hypoperfusion in rodent models has been fraught with 
difficulty.7-9,9,10 Models which employ focal ischemia have repeatedly demonstrated results which do not translate to the clinical setting, and larger 
animal models which allow for whole body hypoperfusion lack access to the full toolset of genetic manipulation possible in the mouse.11,12 However, in recent 
years a mouse model of cardiac arrest and cardiopulmonary resuscitation has emerged which can be adapted to model AKI.13 This model reliably reproduces 
physiologic, functional, anatomic, and histologic outcomes seen in clinical AKI, is rapidly repeatable, and offers all of the significant advantages of a murine surgical 
model, including access to genetic manipulative techniques, low cost relative to large animals, and ease of use. Our group has developed extensive experience 
with use of this model to assess a number of organ-specific outcomes in AKI.14,15

A powerful model for perioperative and critical care related acute kidney injury is presented. Using whole body hypoperfusion induced by cardiac arrest it is possible to nearly replicate the histologic and functional changes of clinical AKI.

Acute Kidney Injury (AKI) is a common, highly lethal, complication of critical illness which has a high mortality1-4 and which is most 
frequently caused ...

Ischemia-reperfusion Model of Acute Kidney Injury and Post Injury Fibrosis in Mice

Ischemia-reperfusion induced acute kidney injury (IR-AKI) is widely used as a model of AKI in mice, but results are often quite variable with high, often unreported mortality rates that may confound analyses. Bilateral renal pedicle clamping is commonly used to induce IR-AKI, but differences between effective clamp pressures and/or renal responses to ischemia between kidneys often lead to more variable results. In addition, shorter clamp times are known to induce more variable tubular injury, and while mice undergoing bilateral injury with longer clamp times develop more consistent tubular injury, they often die within the first 3 days after injury due to severe renal insufficiency. To improve post-injury survival and obtain more consistent and predictable results, we have developed two models of unilateral ischemia-reperfusion injury followed by contralateral nephrectomy. Both surgeries are performed using a dorsal approach, reducing surgical stress resulting from ventral laparotomy, commonly used for mouse IR-AKI surgeries. For induction of moderate injury BALB/c mice undergo unilateral clamping of the renal pedicle for 26 min and also undergo simultaneous contralateral nephrectomy. Using this approach, 50-60% of mice develop moderate AKI 24 hr after injury but 90-100% of mice survive. To induce more severe AKI, BALB/c mice undergo renal pedicle clamping for 30 min followed by contralateral nephrectomy 8 days after injury. This allows functional assessment of renal recovery after injury with 90-100% survival. Early post-injury tubular damage as well as post injury fibrosis are highly consistent using this model.

We describe models of moderate and severe ischemia-reperfusion-induced kidney injury in which the mice undergo unilateral renal pedicle clamping followed by simultaneous or delayed contralateral nephrectomy, respectively. These models consistently give rise to renal dysfunction and post-injury fibrosis, but injury severity and survival are dependent on mouse background, age and surgical equipment.

Ischemia-reperfusion induced acute kidney injury (IR-AKI) is widely used as a model of AKI in mice, but results are often quite variable with high, often ...

Renal Ischaemia Reperfusion Injury: A Mouse Model of Injury and Regeneration

Renal ischaemia reperfusion injury (IRI) is a common cause of acute kidney injury (AKI) in patients and occlusion of renal blood flow is unavoidable during renal transplantation. Experimental models that accurately and reproducibly recapitulate renal IRI are crucial in dissecting the pathophysiology of AKI and the development of novel therapeutic agents. Presented here is a mouse model of renal IRI that results in reproducible AKI. This is achieved by a midline laparotomy approach for the surgery with one incision allowing both a right nephrectomy that provides control tissue and clamping of the left renal pedicle to induce ischaemia of the left kidney. By careful monitoring of the clamp position and body temperature during the period of ischaemia this model achieves reproducible functional and structural injury. Mice sacrificed 24 hr&#160;following surgery demonstrate loss of renal function with elevation of the serum or plasma creatinine level as well as structural kidney damage with acute tubular necrosis evident. Renal function improves and the acute tissue injury resolves during the course of 7 days following renal IRI such that this model may be used to study renal regeneration. This model of renal IRI has been utilized to study the molecular and cellular pathophysiology of AKI as well as analysis of the subsequent renal regeneration.

The mouse model of renal ischaemia reperfusion injury described here comprises of a right nephrectomy that provides control tissue and clamping of the left renal pedicle to induce ischaemia that results in acute kidney injury. This model uses a midline laparotomy approach with all steps performed via one incision.

Renal ischaemia reperfusion injury (IRI) is a common cause of acute kidney injury (AKI) in patients and occlusion of renal blood flow is unavoidable ...

A Murine Model of Irreversible and Reversible Unilateral Ureteric Obstruction

Obstruction of the kidney may affect native or transplanted kidneys and results in kidney injury and scarring. Presented here is a model of obstructive nephropathy induced by unilateral ureteric obstruction (UUO), which can either be irreversible (UUO) or reversible (R-UUO). In the irreversible UUO model, the ureter may be obstructed for variable periods of time in order to induce increasingly severe renal inflammation and interstitial fibrotic scarring. In the reversible R-UUO model the ureter is obstructed to induce hydronephrosis, tubular dilation and inflammation. After a suitable period of time the ureteric obstruction is then surgically reversed by anastomosis of the severed previously obstructed ureter to the bladder in order to allow complete decompression of the kidney and restoration of urinary flow to the bladder. The irreversible UUO model has been used to investigate various aspects of renal inflammation and scarring including the pathogenesis of disease and the testing of potential anti-inflammatory or anti-fibrotic therapies. The more challenging model of R-UUO has been used by some investigators and does offer significant research potential as it allows the study of inflammatory and immune processes and tissue remodeling in an injured and scarred kidney following the removal of the injurious stimulus. As a result, the R-UUO model offers investigators the opportunity to explore the resolution of kidney inflammation together with key aspects of tissue repair. These experimental models are of relevance to human disease as patients often present with obstruction of the renal tract that requires decompression and are commonly left with significant residual kidney impairment that has no current treatment options and may lead to eventual end stage kidney failure.

The murine model of irreversible unilateral ureteric obstruction (UUO) is presented together with the model of reversible UUO in which the ureteric obstruction is relieved by anastomosis of the severed ureter into the bladder. These models enable the study of renal inflammation and scarring as well as tissue remodeling.

Obstruction of the kidney may affect native or transplanted kidneys and results in kidney injury and scarring. Presented here is a model of obstructive ...

A Quantitative Detection Method for MicroRNAs in the Kidney of an Ischemic Kidney Injury Mouse Model

MicroRNAs (miRNAs) are involved in various disease states and are effective biomarkers for the early diagnosis of diseases and treatment in mice. However, standard protocols for the purification of miRNAs and detection of their expression in the kidneys of acute kidney injury (AKI) mice have not been well established. This study developed an effective and simple protocol to purify and quantify miRNAs in the kidneys of an AKI mouse model induced by renal ischemia-reperfusion using quantitative real-time reverse-transcription polymerase chain reaction (qRT-PCR). This protocol comprises five steps: 1) induction of AKI by renal ischemia-reperfusion, 2) harvesting of kidneys, 3) purification of total RNA, including miRNAs, from kidneys, 4) cDNA synthesis by reverse transcription of miRNA, and 5) qRT-PCR to detect miRNA expression. Using this protocol, the renal ischemia-reperfusion injury model can be generated with mild to severe forms of AKI. Additionally, if the procedure is followed properly, a consistent AKI model with minimal individual differences can be obtained. This qRT-PCR assay shows a very wide dynamic range and enables the discrimination of mature miRNAs, which can be accurately quantified with high specificity. This protocol can be used to study the miRNA expression profile in AKI kidneys.

This article presents a protocol for detecting microRNA expression in the kidneys of an acute kidney injury mouse model using quantitative real-time reverse-transcription polymerase chain reaction. This protocol emphasizes an ischemic kidney injury mouse model and the careful extraction of microRNA samples.

MicroRNAs (miRNAs) are involved in various disease states and are effective biomarkers for the early diagnosis of diseases and treatment in mice. However, ...

The Mouse Isolated Perfused Kidney Technique

The mouse isolated perfused kidney (MIPK) is a technique for keeping a mouse kidney under ex vivo conditions perfused and functional for 1 hr. This is a prerequisite for studying the physiology of the isolated organ and for many innovative applications that may be possible in the future, including perfusion decellularization for kidney bioengineering or the administration of anti-rejection or genome-editing drugs in high doses to prime the kidney for transplantation. During the time of the perfusion, the kidney can be manipulated, renal function can be assessed, and various pharmaceuticals administered. After the procedure, the kidney can be transplanted or processed for molecular biology, biochemical analysis, or microscopy.
This paper describes the perfusate and the surgical technique needed for the ex vivo perfusion of mouse kidneys. Details of the perfusion apparatus are given and data are presented showing the viability of the kidney&#39;s preparation: renal blood flow, vascular resistance, and urine data as functional, transmission electron micrographs of different nephron segments as morphological readouts, and western blots of transport proteins of different nephron segments as molecular readout.

The mouse isolated perfused kidney (MIPK) is a technique for keeping a mouse kidney under ex vivo conditions perfused and functional for 1 hr. The buffers and surgical technique are described in detail.

The mouse isolated perfused kidney (MIPK) is a technique for keeping a mouse kidney under ex vivo conditions perfused and functional for 1 hr. This is a ...

Biology

Technical Refinement of a Bilateral Renal Ischemia-Reperfusion Mouse Model for Acute Kidney Injury Research

Cardiac arrest poses a large public health burden. Acute kidney injury (AKI) is an adverse marker in survivors of cardiac arrest following the return of spontaneous circulation (ROSC) after successful cardiopulmonary resuscitation. Conversely, recovery of kidney function from AKI is a predictor of favorable neurological outcomes and hospital discharge. However, an effective intervention to prevent kidney damage caused by cardiac arrest after ROSC is lacking, suggesting that additional therapeutic strategies are required. Renal hypoperfusion and reperfusion are two pathophysiological mechanisms that cause AKI after cardiac arrest. Animal models of ischemia-reperfusion-induced AKI (IR-AKI) of both kidneys are comparable with patients with AKI following ROSC in a clinical setting. However, IR-AKI of both kidneys is technically challenging to analyze because the model is associated with high mortality and wide variation in kidney damage, which may affect the analysis. Lightweight mice were chosen, placed under general anesthesia with isoflurane, subjected to surgery with a dorsolateral approach, and their body temperature maintained during operation, thereby reducing tissue damage and establishing a reproducible acute renal IR-AKI research protocol.

This study established a protocol focusing on the technical refinement of a mouse model of bilateral renal ischemia-reperfusion for acute kidney injury research.

Cardiac arrest poses a large public health burden. Acute kidney injury (AKI) is an adverse marker in survivors of cardiac arrest following the return of ...

Developing Murine Acute Kidney Injury Model Using Bilateral Ischemia-Reperfusion

Bilateral Renal Ischemia-Reperfusion Model for Acute Kidney Injury in Mice

Acute kidney injury (AKI) is defined as a rapid decline in renal function, in which persistent kidney dysfunction gradually progresses to chronic kidney disease (CKD) due to the irreversible loss of nephrons and their maladaptive repair. In recent years, the incidence of AKI has been increasing concerning diverse etiologies, including volume depletion, sepsis, nephrotoxicity, muscle injury, and major trauma, in which ischemia-reperfusion injury (IRI)&#160;accounts for most episodes. Development of the IRI model in mice is induced by surgical clamping of the renal pedicles, which provides powerful and controllable tools for preclinical models of AKI. Importantly, the IRI model is deployed at different stages of the AKI development, especially in the processes of AKI to CKD. Despite the IRI model being widely practiced in many laboratories, a series of variables still influence the results of this model. Here, we describe the procedure of IRI model development to provide a repeatable and reliable method for researchers to explore the underlying pathogenesis in the development of AKI and the progression of AKI to CKD.

The ischemia-reperfusion injury (IRI) model can be used at different stages of acute kidney injury (AKI) development, especially during AKI to chronic kidney disease (CKD) progression. Here, we describe the procedure for IRI model development in mice via a trans-abdominal approach, clamping renal pedicles via a vascular clip to induce ischemic injury.

Acute kidney injury (AKI) is defined as a rapid decline in renal function, in which persistent kidney dysfunction gradually progresses to chronic kidney ...